FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Gardasil 9

MSD

Injektionsvätska, suspension, förfylld spruta
(klar vätska med en vit fällning.)

9-valent vaccin mot humant papillom virus (HPV-typ 6, 11, 16, 18, 31, 33, 45, 52, 58)

ATC-kod: J07BM03
Utbytbarhet: Ej utbytbar
Läkemedel från MSD omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

L1 protein, humant papillomvirus (HPV) typ 11, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 16, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 18, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 31, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 33, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 45, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 52, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 58, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.

L1 protein, humant papillomvirus (HPV) typ 6, virusliknande partiklar, rekombinant

Miljörisk: Användning av vacciner bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (Ref. I).


Even though biomolecules, such as vaccines and hormones, are exempted

they should still be regarded as biologically active.


References

  1. Committee for Medicinal Products for Human Use (CHMP); Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006, Ref EMEA/CPMP/SWP/4447/00.